Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Systemic Immune Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT05367986
What this trial is testing

Electro-acupuncture at Zusanli, Qihai, and Guanyuan Acupoints Regulate Immune Function in Patients With Sepsis

Who this might be right for
SepsisImmune Dysfunction
Guangdong Provincial Hospital of Traditional Chinese Medicine 78
Testing effectiveness (Phase 2)Study completedNCT02962960
What this trial is testing

Characterize the Pharmacokinetics, Pharmacodynamics, and Safety of Anifrolumab in Adult Type I Interferon Test High Systemic Lupus Erythematosus Subject With Active Skin Manifestations

Who this might be right for
Systemic Lupus Erythematosus
AstraZeneca 36
Testing effectiveness (Phase 2)Study completedNCT00091260
What this trial is testing

CC-5013 With or Without Dexamethasone in Treating Patients With Primary Systemic Amyloidosis

Who this might be right for
Multiple Myeloma
Vaishali Sanchorawala 82
Testing effectiveness (Phase 2)Looking for participantsNCT07225543
What this trial is testing

2-HOBA in Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erthematosus (SLE)
Vanderbilt University Medical Center 42
Post-approval studies (Phase 4)Ended earlyNCT01316133
What this trial is testing

Evaluate the Efficacy and Safety of Tacrolimus With Steroid in Korean Lupus Nephritis Patients

Who this might be right for
Lupus Nephritis
Astellas Pharma Korea, Inc. 37
Early research (Phase 1)Enrolling By InvitationNCT07038447
What this trial is testing

KITE-363 in Participants With Refractory Autoimmune Diseases

Who this might be right for
Systemic Lupus ErythematosusLupus NephritisSystemic Sclerosis+1 more
Kite, A Gilead Company 52
Testing effectiveness (Phase 2)Study completedNCT02550652
What this trial is testing

Evaluate the Safety and Efficacy of Obinutuzumab Compared With Placebo in Participants With Lupus Nephritis (LN)

Who this might be right for
Lupus Nephritis
Hoffmann-La Roche 126
Early research (Phase 1)Study completedNCT00001515
What this trial is testing

Diagnostic Effectiveness of Virtual Bronchoscopy

Who this might be right for
Bronchogenic CarcinomaChronic Granulomatous DiseaseJob's Syndrome+2 more
National Institutes of Health Clinical Center (CC) 120
Not applicableStudy completedNCT00890435
What this trial is testing

Decision Making About Participating in Pharmacokinetic Studies in Patients Enrolled in a Phase I Treatment Clinical Trial

Who this might be right for
Brain and Central Nervous System TumorsLeukemiaUnspecified Adult Solid Tumor, Protocol Specific+1 more
Children's Oncology Group 53
Large-scale testing (Phase 3)Study completedNCT00624338
What this trial is testing

Atacicept Phase 2/3 in Generalized Systemic Lupus Erythematosus (APRIL-SLE)

Who this might be right for
Lupus Erythematosus, Systemic
EMD Serono 461
Not applicableLooking for participantsNCT07575347
What this trial is testing

Periodontal Disease in Rare Renal Disorders (PERIO-RA-RE)

Who this might be right for
Periodontal DiseasePeriodontitisCKD+6 more
Stefan Lujinschi 100
Not applicableEnded earlyNCT03557749
What this trial is testing

Monitoring of Immune and Microbial Reconstitution in (HCT) and Novel Immunotherapies

Who this might be right for
Immune and Microbial ReconstitutionSystemic Viral InfectionAcute-graft-versus-host Disease+5 more
Masonic Cancer Center, University of Minnesota 210
Large-scale testing (Phase 3)Looking for participantsNCT06711887
What this trial is testing

Phase III Extension Study of Efficacy and Safety of Ianalumab With or Without Study Treatment Withdrawal in Participants With Lupus Nephritis (SIRIUS-LN Extension)

Who this might be right for
Lupus Nephritis
Novartis Pharmaceuticals 348
Early research (Phase 1)Study completedNCT00003451
What this trial is testing

Interleukin-12 Followed by Interferon Alfa in Treating Patients With Advanced Cancer

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+4 more
National Cancer Institute (NCI) 40
Not applicableStudy completedNCT04527172
What this trial is testing

Neuromuscular Ultrasonography Utility for Detection of Peripheral Neuropathy in Systemic Lupus Erythematosus

Who this might be right for
Peripheral NeuropathySystem; Lupus Erythematosus
Assiut University 55
Not applicableStudy completedNCT01835457
What this trial is testing

Concentration/Meditation Limits Inflammation

Who this might be right for
Autoimmune Diseases
Radboud University Medical Center 30
Not applicableUnknownNCT05314881
What this trial is testing

NCF Gene & TNFSF4 in SLE Patients

Who this might be right for
System; Lupus Erythematosus
Assiut University 65
Early research (Phase 1)Active Not RecruitingNCT03016377
What this trial is testing

Administration of Autologous CAR-T CD19 Antigen With Inducible Safety Switch in Patients With Relapsed/Refractory ALL

Who this might be right for
Acute Lymphoblastic LeukemiaImmune System DiseasesImmunoproliferative Disorders
UNC Lineberger Comprehensive Cancer Center 15
Early research (Phase 1)Study completedNCT00072592
What this trial is testing

An Open Label Pilot Study Examining the Use of Rituximab in Patients With Wegener's Granulomatosis Who Have Experienced Disease Relapse on Standard Therapies

Who this might be right for
Wegener's Granulomatosis
National Institute of Allergy and Infectious Diseases (NIAID) 10
Early research (Phase 1)Study completedNCT02165345
What this trial is testing

Extension Study Evaluating the Safety and Efficacy of Subcutaneous Tocilizumab (RoActemra/Actemra) Administration in Systemic and Polyarticular-Course Juvenile Idiopathic Arthritis

Who this might be right for
Juvenile Idiopathic Arthritis
Hoffmann-La Roche 82
Next Page